Enteric fever, predominantly caused by Salmonella Typhi and Paratyphi, remains a significant health issue worldwide, particularly in developing nations. This article aims to provide an updated approach to its diagnosis and treatment, based on recent research and advancements.
Early diagnosis of enteric fever is crucial for effective management. Traditionally, blood culture has been the gold standard for diagnosis. However, its sensitivity is not optimal, especially in early disease stages or after antibiotic therapy. Recent advancements include nucleic acid amplification tests (NAATs), which have shown promising results in terms of sensitivity and specificity. Moreover, serological tests like Typhidot and Tubex have improved, although their reliability varies across different populations.
Treatment of enteric fever mainly involves antibiotic therapy. The choice of antibiotics has evolved due to increasing antibiotic resistance. Fluoroquinolones, once the first-line treatment, have seen decreased efficacy due to widespread resistance. Current guidelines recommend third-generation cephalosporins like ceftriaxone or cefixime, or azithromycin as first-line treatment. However, the choice should be guided by local susceptibility patterns. Moreover, supportive care including hydration and fever control is vital.
Prevention plays a key role in managing enteric fever. This includes provision of safe drinking water, improved sanitation, and vaccination. Two vaccines, Vi polysaccharide vaccine and Ty21a, are currently available. However, their use is recommended in high-risk areas or for travelers to such areas, as their efficacy is not 100%.
Enteric fever continues to pose a significant health challenge, especially in resource-limited settings. Early diagnosis and appropriate treatment are essential for patient recovery. The emergence of antibiotic resistance necessitates continuous surveillance and updating of treatment guidelines. Preventive strategies, including vaccination and improvements in water and sanitation, are equally important in controlling the disease.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation